AGTC Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-11-30 | Rosen James | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | Rosen James | director | 0 | U-Tender | D | 1,000 | 0.00 | 0.00 |
| 2022-11-30 | VANLENT ANNE | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | Robinson James A. Jr. | director | 0 | D-Return | D | 25,000 | 2.17 | 54,250.00 |
| 2022-11-30 | Aliski William | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | Aliski William | director | 0 | U-Tender | D | 8,500 | 0.00 | 0.00 |
| 2022-11-30 | Koenig Scott | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | Koenig Scott | director | 0 | U-Tender | D | 34,246 | 0.00 | 0.00 |
| 2022-11-30 | Hashad Yehia | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | HURWITZ EDWARD | director | 0 | D-Return | D | 14,000 | 2.17 | 30,380.00 |
| 2022-11-30 | HURWITZ EDWARD | director | 0 | U-Tender | D | 1,800 | 0.00 | 0.00 |
| 2022-11-30 | Washer Susan B. | director, officer: President and CEO | 0 | D-Return | D | 442,000 | 0.40 | 176,800.00 |
| 2022-11-30 | Washer Susan B. | director, officer: President and CEO | 0 | U-Tender | D | 143,021 | 0.00 | 0.00 |
| 2022-11-30 | Lieber Jonathan I | officer: Chief Financial Officer | 0 | D-Return | D | 154,700 | 0.40 | 61,880.00 |
| 2022-11-30 | Schneider Susan | officer: Chief Medical Officer | 0 | D-Return | D | 142,300 | 0.40 | 56,920.00 |
| 2022-11-30 | DOyley-Gay Hope | officer: General Counsel | 0 | D-Return | D | 147,900 | 0.40 | 59,160.00 |
| 2022-11-30 | Potter Stephen W | officer: Chief Business Officer | 0 | D-Return | D | 133,100 | 0.40 | 53,240.00 |
| 2022-11-30 | Potter Stephen W | officer: Chief Business Officer | 0 | D-Return | D | 133,100 | 0.40 | 53,240.00 |
| 2022-11-30 | Potter Stephen W | officer: Chief Business Officer | 8,750 | U-Tender | D | 47,133 | 0.00 | 0.00 |
| 2022-11-30 | Scaria Abraham | officer: Chief Scientific Officer | 0 | D-Return | D | 124,500 | 0.40 | 49,800.00 |
| 2022-11-30 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 0 | D-Return | D | 34,500 | 3.70 | 127,650.00 |
| 2022-11-30 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 0 | D-Return | D | 34,500 | 3.70 | 127,650.00 |
| 2022-11-30 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 42,500 | U-Tender | D | 8,506 | 0.00 | 0.00 |
| 2022-08-21 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 51,006 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-08-21 | Potter Stephen W | officer: Chief Business Officer | 133,100 | A-Award | A | 133,100 | 0.40 | 53,240.00 |
| 2022-08-21 | DOyley-Gay Hope | officer: General Counsel | 147,900 | A-Award | A | 147,900 | 0.40 | 59,160.00 |
| 2022-08-21 | Scaria Abraham | officer: Chief Scientific Officer | 124,500 | A-Award | A | 124,500 | 0.40 | 49,800.00 |
| 2022-08-21 | Schneider Susan | officer: Chief Medical Officer | 142,300 | A-Award | A | 142,300 | 0.40 | 56,920.00 |
| 2022-08-21 | Lieber Jonathan I | officer: Chief Financial Officer | 154,700 | A-Award | A | 154,700 | 0.40 | 61,880.00 |
| 2022-08-21 | Washer Susan B. | director, officer: President and CEO | 442,000 | A-Award | A | 442,000 | 0.40 | 176,800.00 |
| 2022-07-01 | Potter Stephen W | officer: Chief Business Officer | 55,883 | S-Sale | D | 8,070 | 0.77 | 6,250.22 |
| 2022-05-27 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 21,006 | S-Sale | D | 3,994 | 0.85 | 3,375.73 |
| 2022-02-18 | Washer Susan B. | director, officer: President and CEO | 0 | M-Exempt | D | 120,686 | 0.35 | 42,240.10 |
| 2022-02-18 | Washer Susan B. | director, officer: President and CEO | 143,021 | S-Sale | D | 9,950 | 2.18 | 21,691.00 |
| 2022-02-18 | Washer Susan B. | director, officer: President and CEO | 152,971 | M-Exempt | A | 120,686 | 0.35 | 42,240.10 |
| 2021-12-13 | DOyley-Gay Hope | officer: General Counsel | 180,000 | A-Award | A | 180,000 | 2.02 | 363,600.00 |
| 2021-12-06 | Scaria Abraham | officer: Chief Scientific Officer | 220,000 | A-Award | A | 220,000 | 1.98 | 435,600.00 |
| 2021-11-30 | Robinson James A. Jr. | director | 25,000 | A-Award | A | 25,000 | 2.17 | 54,250.00 |
| 2021-11-30 | VANLENT ANNE | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | Rosen James | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | Magovcevic-Liebisch Ivana | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | Koenig Scott | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | HURWITZ EDWARD | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | Hashad Yehia | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-30 | Aliski William | director | 14,000 | A-Award | A | 14,000 | 2.17 | 30,380.00 |
| 2021-11-08 | Schneider Susan | officer: Chief Medical Officer | 180,000 | A-Award | A | 180,000 | 2.76 | 496,800.00 |
| 2021-11-01 | Washer Susan B. | director, officer: President and CEO | 0 | M-Exempt | D | 3,877 | 3.50 | 13,569.50 |
| 2021-11-01 | Washer Susan B. | director, officer: President and CEO | 32,285 | M-Exempt | A | 3,877 | 3.50 | 13,569.50 |
| 2021-09-20 | Lieber Jonathan I | officer: Chief Financial Officer | 202,000 | A-Award | A | 202,000 | 3.30 | 666,600.00 |
| 2021-08-16 | Hashad Yehia | director | 25,000 | A-Award | A | 25,000 | 3.42 | 85,500.00 |
| 2021-08-15 | Potter Stephen W | officer: VP and Chief Business Officer | 63,953 | F-InKind | D | 5,724 | 3.58 | 20,491.92 |
| 2021-08-05 | Reynolds Gerald Anthony | officer: Chief Accounting Officer | 34,500 | A-Award | A | 34,500 | 3.70 | 127,650.00 |
| 2021-07-27 | Washer Susan B. | director, officer: President and CEO | 275,000 | A-Award | A | 275,000 | 3.74 | 1,028,500.00 |
| 2021-07-27 | Potter Stephen W | officer: VP and Chief Business Officer | 60,000 | A-Award | A | 60,000 | 3.74 | 224,400.00 |
| 2021-06-17 | Potter Stephen W | officer: VP and Chief Business Officer | 69,677 | A-Award | A | 35,000 | 0.00 | 0.00 |
| 2020-12-16 | Koenig Scott | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-12-16 | Aliski William | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-12-16 | HURWITZ EDWARD | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-12-16 | Magovcevic-Liebisch Ivana | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-12-16 | Rosen James | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-12-16 | VANLENT ANNE | director | 12,000 | A-Award | A | 12,000 | 4.72 | 56,640.00 |
| 2020-08-15 | Shearman Mark S | officer: Chief Scientific Officer | 33,277 | F-InKind | D | 5,723 | 5.77 | 33,021.71 |
| 2020-08-15 | Potter Stephen W | officer: VP and Chief Business Officer | 34,677 | F-InKind | D | 5,723 | 5.77 | 33,021.71 |
| 2020-08-05 | Shearman Mark S | officer: Chief Scientific Officer | 50,000 | A-Award | A | 50,000 | 5.50 | 275,000.00 |
| 2020-08-05 | Washer Susan B. | director, officer: President and CEO | 169,000 | A-Award | A | 169,000 | 5.50 | 929,500.00 |
| 2020-08-05 | Sullivan William A. | officer: Chief Financial Officer | 50,000 | A-Award | A | 50,000 | 5.50 | 275,000.00 |
| 2020-08-05 | Potter Stephen W | officer: VP and Chief Business Officer | 50,000 | A-Award | A | 50,000 | 5.50 | 275,000.00 |
| 2019-12-26 | Krol Patrick Johan Hendrik | 10 percent owner | 1,780,762 | S-Sale | D | 81,162 | 5.24 | 425,288.88 |
| 2019-12-04 | HURWITZ EDWARD | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-12-04 | Rosen James | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-12-04 | VANLENT ANNE | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-12-04 | Koenig Scott | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-12-04 | Magovcevic Ivana | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-12-04 | Aliski William | director | 10,000 | A-Award | A | 10,000 | 3.02 | 30,200.00 |
| 2019-11-19 | Krol Patrick Johan Hendrik | 10 percent owner | 1,861,924 | P-Purchase | A | 2,544 | 2.79 | 7,097.76 |
| 2019-09-18 | Washer Susan B. | director, officer: President and CEO | 28,408 | M-Exempt | A | 5,700 | 3.50 | 19,950.00 |
| 2019-09-18 | Washer Susan B. | director, officer: President and CEO | 13,841 | M-Exempt | D | 5,700 | 3.50 | 19,950.00 |
| 2019-08-15 | Washer Susan B. | director, officer: President and CEO | 100,000 | A-Award | A | 100,000 | 3.00 | 300,000.00 |
| 2019-08-15 | Shearman Mark S | officer: Chief Scientific Officer | 39,000 | A-Award | A | 39,000 | 0.00 | 0.00 |
| 2019-08-15 | Shearman Mark S | officer: Chief Scientific Officer | 52,000 | A-Award | A | 52,000 | 3.00 | 156,000.00 |
| 2019-08-15 | Potter Stephen W | officer: VP and Chief Business Officer | 40,400 | A-Award | A | 39,000 | 0.00 | 0.00 |
| 2019-08-15 | Potter Stephen W | officer: VP and Chief Business Officer | 52,000 | A-Award | A | 52,000 | 3.00 | 156,000.00 |
| 2019-08-15 | Sullivan William A. | officer: Chief Financial Officer | 52,000 | A-Award | A | 52,000 | 3.00 | 156,000.00 |
| 2019-08-15 | Krex Brian | officer: General Counsel | 13,000 | A-Award | A | 13,000 | 3.00 | 39,000.00 |
| 2019-07-29 | Heah Theresa | officer: Chief Medical Officer | 100,000 | A-Award | A | 100,000 | 3.91 | 391,000.00 |
| 2019-07-29 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 100,000 | A-Award | A | 100,000 | 3.91 | 391,000.00 |
| 2019-07-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 56,644 | A-Award | A | 2,000 | 0.00 | 0.00 |
| 2019-07-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 56,052 | F-InKind | D | 592 | 3.75 | 2,220.00 |
| 2019-06-11 | Feinsod Matthew | officer: Interim Chief Medical Officer | 54,644 | F-InKind | D | 685 | 3.70 | 2,534.50 |
| 2019-06-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 55,329 | A-Award | A | 2,000 | 0.00 | 0.00 |
| 2019-05-28 | Koenig Scott | director | 0 | M-Exempt | D | 32,018 | 0.35 | 11,206.30 |
| 2019-05-28 | Koenig Scott | director | 34,246 | M-Exempt | A | 32,018 | 0.35 | 11,206.30 |
| 2019-05-13 | Feinsod Matthew | officer: Interim Chief Medical Officer | 53,329 | F-InKind | D | 685 | 4.06 | 2,781.10 |
| 2019-05-13 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 54,014 | A-Award | A | 2,000 | 0.00 | 0.00 |
| 2019-04-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 52,620 | A-Award | A | 2,000 | 0.00 | 0.00 |
| 2019-04-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 52,014 | F-InKind | D | 606 | 4.61 | 2,793.66 |
| 2019-03-25 | Krex Brian | officer: General Counsel | 125,000 | A-Award | A | 125,000 | 4.20 | 525,000.00 |
| 2019-03-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 51,287 | A-Award | A | 2,000 | 0.00 | 0.00 |
| 2019-03-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 50,620 | F-InKind | D | 667 | 3.97 | 2,647.99 |
| 2019-02-11 | Feinsod Matthew | officer: Exec. VP, Global Strat. & Dev. | 50,078 | A-Award | A | 2,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.